BAX Return on Equity (ROE) Analysis
Higher than 14% of Healthcare sector peers
Updated 125h ago·SEC filings & market data
Key Takeaway
Return on Equity (ROE) measures how much profit a company generates from each dollar of shareholders' equity; at -14.4%, Baxter is currently losing money relative to its equity base.
Sector Performance
14th percentileBAX
-14.4%
Sector Median
11.3%
Sector Avg
72.2%
Prior Period
-15.0%(Jul 2026)
Deep Analysis
Return on Equity (ROE) measures how much profit a company generates from each dollar of shareholders' equity; at -14.4%, Baxter is currently losing money relative to its equity base.
This sits far below the healthcare sector median of 7.7%, placing Baxter in the 21st percentile among sector peers, meaning roughly four out of five peers perform better. The trend direction over the last 8 quarters is N/A, and the year-over-year change is also N/A, but the quarter-over-quarter change is +4.0%, showing a slight improvement from the prior -15.0% reading. The combination of a deeply negative ROE with only a modest quarterly uptick implies ongoing capital destruction, though the improvement offers a slim near-term anchor against further deterioration. This metric directly supports the overall CAUTIOUS verdict, as the level remains well below profitability while the single-quarter gain does not offset the weak competitive standing.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about BAX?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
How does BAX's Return on Equity (ROE) compare to its sector?
BAX's Return on Equity (ROE) of -14.4% compares to a Healthcare sector median of 11.3%, placing it in the 14th percentile.
Who are BAX's closest peers by Return on Equity (ROE)?
The closest Healthcare peers by Return on Equity (ROE) include: ABT (12.5%), ALGN (10.1%), TMO (13.5%), TECH (9.0%), VEEV (13.9%).
Learn More About Return on Equity (ROE)
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master BAX's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full BAX research report →BAX
-14.4%
Sector Median
11.3%
Sector Avg
72.2%
How BAX's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.